Heiko Becker

15PUBLICATIONS
123CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursMolecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 19, 2026
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Oct 07, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial.

Inga Hund, Maria Elena Hess, Geoffroy Andrieux

|Jun 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Dominik Schmidt, Cornelia Endres, Rouven Hoefflin

|Feb 15, 2023
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke.

Ernst Mayerhofer, Christoph Strecker, Heiko Becker

|Dec 11, 2022
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.

Asmaa Elrakaybi, Dietrich A Ruess, Michael Lübbert

Pageof 3

Frequent Collaborators

3 joint publications

Geoffroy Andrieux

3 joint publications

Melanie Boerries

3 joint publications

Julius Wehrle

3 joint publications

Khalid Shoumariyeh